PharmaResearch just kicked off something big. On September 11 to 12, the company held official REJURAN launch symposiums in Riyadh and Jeddah.
Together, the two events drew approximately 400 local dermatologists, plastic surgeons, and industry representatives. Clearly, they came curious.
Saudi Arabia ranks among the Middle East's largest healthcare and aesthetics markets. Meanwhile, demand for nonsurgical procedures keeps climbing, especially in Riyadh and Jeddah.
Interestingly, patients now want healthier skin, not just more volume. Therefore, regenerative aesthetics is taking center stage.
Attendees explored DOT™ PN technology and REJURAN's clinical applications. Notably, physicians loved the precise eye-area treatment cases.
Additionally, Korean experts shared practical techniques, including patient-friendly approaches and combination treatments with energy-based devices (EBDs).
PharmaResearch earned Saudi medical device approval in February 2026 and began distribution through a partner in May. Now, it plans to expand its network of local key opinion leaders (KOLs).
Ultimately, the company will keep strengthening physician education and academic marketing. It wants Saudi Arabia to anchor growth across the GCC region and, eventually, MENA.
